Form D Explorer

Inspect source fieldsReport a record issue

Form D — Theriva Biologics, Inc.

0001104659-25-101914 · filed Oct 24, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$13,109,494
Reported amount sold
$13,109,494
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Theriva Biologics, Inc.
CIK
894158
Entity
Corporation
Jurisdiction
NEVADA
Year incorporated
—
Address
9605 MEDICAL CENTER DRIVE
ROCKVILLE, Maryland 20850
Phone
301-417-4364

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗